Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Henry Schein (Nasdaq: HSIC) will release its first quarter 2026 financial results before market open on Tuesday, May 5, 2026 and will host a live webcast conference call beginning at 8:00 A.M. ET.
Speakers include CEO Frederick M. Lowery and SVP & CFO Ronald N. South. Investors can access the live webcast via the company’s investor webcasts page and a replay will be posted after the presentation.
Henry Schein (Nasdaq: HSIC) will reduce its Board of Directors from fifteen to ten members after the 2026 Annual Meeting on May 21, 2026. Stanley M. Bergman will retire after 44 years on the board and be named Chairman Emeritus.
Four additional directors will not stand for reelection, and ten incumbent directors are nominated for election to the reduced board, which the board says preserves experience and diverse perspectives.
Henry Schein (Nasdaq: HSIC) was named one of the 2026 World's Most Ethical Companies® by Ethisphere for the 15th consecutive year, part of the program's 20th annual class. The company highlighted ethics, governance, and its 25-year Henry Schein Cares program, plus nearly $18 million in 2025 cash and product support.
The recognition reflects documented programs across governance, compliance, training, third‑party risk, and social impact measured via Ethisphere’s Ethics Quotient®.
Henry Schein One (HSIC) unveiled the next era of Dentrix Ascend on March 10, 2026, launching three new packages—Ascend Essentials, Pro, and Accelerate—built on a unified, agentic AI platform to streamline clinical workflows, imaging, and revenue cycle management.
Key metrics: the platform serves >48,000 practices, 90% of the top 50 DSOs, supports ~100 million claims annually, and recorded 22 million digital forms and 191 million eligibility checks in 2025.
Henry Schein (NASDAQ:HSIC) will present at two investor conferences in Miami in March. Presentations are scheduled for March 9, 2026 at 10:00 a.m. ET and March 10, 2026 at 10:30 a.m. ET, with live webcasts and subsequent replays available on the company website.
Investors can access live audio via the Henry Schein investor webcast page; replays will be posted after each presentation.
Henry Schein (Nasdaq: HSIC) reported Q4 2025 net sales of $3.4 billion, up 7.7% year-over-year, driven by equipment, specialty products and technology. GAAP diluted EPS was $0.85 and non-GAAP diluted EPS was $1.34 for Q4. Full-year 2025 sales were $13.2 billion (+4.0%).
Management announced 2026 guidance of non-GAAP diluted EPS $5.23–$5.37 and total sales growth ~3–5%, and reported $850 million of share repurchases in 2025 with $780 million available.
Henry Schein One (NASDAQ:HSIC) launched Image Verify, an AI-enabled image quality tool natively embedded in Dentrix and Dentrix Ascend to assess clinical images in real time at capture.
The company says Image Verify flags blur, misalignment, and incomplete coverage to prevent documentation-related denials; Dentrix customers also receive a new Claims Manager this month.
Henry Schein One (NYSE:HSIC) announced a direct integration connecting Align Technology’s iTero intraoral scanners with Dentrix, Dentrix Ascend, and Dentally, enabling automatic import of scans into patient records and eliminating manual uploads.
The integration, built with Align Technology and piloted with Heartland Dental, aims to streamline diagnosis, treatment planning, and practice workflows and is available to eligible customers in North America and select international markets.
Henry Schein (Nasdaq: HSIC) is a longtime national sponsor of the American Dental Association Foundation’s Give Kids A Smile (GKAS) program, which has reached more than 10.2 million children since 2003. The 2026 effort aims to deliver services to an estimated 325,000 children via 1,200 events and 23,000 volunteers.
Henry Schein has contributed over $20 million in products to GKAS and prepared more than 2,600 dental kits for volunteers in 2026, reinforcing the company’s charitable and community health commitments.
Henry Schein (Nasdaq: HSIC) will release its fourth quarter 2025 financial results before the market opens on Tuesday, February 24, 2026.
The company will host a live webcast of its earnings conference call the same day beginning at 8:00 a.m. Eastern. Speakers include Stanley M. Bergman, chairman and CEO, and Ronald N. South, SVP and CFO. Investors can access the live call and a replay via the company's investor webcasts page.